FIELD: organic chemistry, medicine, oncology, pharmacy. SUBSTANCE: invention relates to compound of the formula (I) where R is C1-C10-alkyl, phenyl or C7-C10-aralkyl, C2-C10-alkyl substituted with one or two substituents taken from a group consisting of OR1 and NR2R3, C2-C10-alkyl broken by one or two oxygen atoms or a member taken from a group consisting of NR4, cis-CH= CH-, trans-CH=CH-, -C=C- and optionally substituted with one or two hydroxyls (OH) or NR2R3-groups and where R1 is taken from a group consisting of hydrogen atom, C1-C6-alkyl, phenyl, C7-C10-aralkyl, -CHO, -COR5,-S(O2)R5 and C2-C6-alkyl optionally substituted with -NR2R3; R2 and R3 are similar or distinct and taken from a group consisting of hydrogen atom, C1-C10-alkyl, C7-C10-aralkyl, phenyl, C2-C10-alkyl substituted with one or two hydroxyls (OH), -CHO, -COR5,COOR5 and ; R2 and R3 taken with nitrogen atom to which they are bound form ethyleneimine ring or 5- or 6-membered aromatic or nonaromatic heterocycle optionally containing another heteroatom taken from a group consisting of sulfur, oxygen and nitrogen atom; R2 is H and R3 is -C=(NH)NH2 or R2 is -C=(NH)NH2 and R3 is H; R4 is taken from a group consisting of hydrogen atom, C1-C10-alkyl, C2-C10-hydroxyalkyl, C2-C10/ -alkyl substituted with -NR2R3, C7-C10-aralkyl, α,β or V-naphthyl, phenyl, o-, m- or p-tolyl as a free base or its salt with a pharmaceutically acceptable acid. Compounds show cytostatic and antitumor activity. Invention describes a method of synthesis of compounds of the formula (I) and a method of SUPPRESSION of tumors in mammals by administration of a compound of the formula (I) at the dose from 1 to 50 mg/kg body mass per a day. EFFECT: improved method of synthesis, antitumor activity of compounds synthesized. 38 cl, 12 tbl, 30 ex
Title |
Year |
Author |
Number |
2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOL-6-(2H)-ONES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND METHOD OF TREATING TUMOR |
1993 |
- A.Pol Krapcho
- Ehrnesto Menta
- Ambrodzhio Oliva
- Sil'Vano Spinelli
|
RU2130937C1 |
IMPROVED METHODS OF SYNTHESIS OF 6,9-BIS-[(2-AMINOETHYL)- -AMINO]BENZO[G]ISOQUINOLINE-5,10-DIONE MALEATE |
1995 |
- Sil'Vano Spinelli
- Roberto Didomeniko
|
RU2144028C1 |
DIDEOXYDIDEHYDROCARBOCYCLIC NUCLEOSIDES, PHARMACEUTICAL COMPOSITION |
1989 |
- Robert Bins
- Mej Kh'Jua
- Piter Lesli Majers
- Richard Storer
|
RU2114846C1 |
TAXANE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1994 |
- Ivao Odzima
- Ehtsio Bombardelli
|
RU2137764C1 |
1,3-DIOXOINDENE DERIVATIVES, THEREOF PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL ANTIVIRAL COMPOSITION, CONTAINING IT AS ACTIVE INGREDIENT |
2012 |
- Dzung Jang Sik
- Li Chong Kgo
- Choi Ikhl Jang
- Kim Khae Soo
- Kim Pil Kho
- Khan Soo Bong
- Nehjts Jokhan
- Tibo Khendrik Jan
|
RU2566761C2 |
PHENYLCARBAMATES AND USE THEREOF AS ENZYME INHIBITORS OF HYDROLASES OF FATTY ACID AMIDES (FAAH) AND DOPAMINE RECEPTOR D3 (D3DR) MODULATORS |
2014 |
- Bottegoni Dzhovanni
- De Simone Alessio
- Ruda Dzhan Filippo
- Kavalli Andrea
- Bandera Titsiano
- Pomelli Daniele
|
RU2693457C2 |
NEW COMPOUNDS AS POTENTIAL INDUCERS OF TERMINAL DIFFERENTIATION OF TUMOR CELLS, A PHARMACEUTICAL COMPOSITION BASED ON SAID |
1992 |
- Ronal'D Breslou
- Pol A.Marks
- Richard A.Rifkind
- Branko Dzhursik
|
RU2128643C1 |
SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING ANTIVIRAL EFFECT BASED ON THEREOF |
1993 |
- Leroj B.Taunsend
- Dzhon Charl'Z Drehch
- Stiven Spenser Gud
- S'Juzn Mehri Del'Judzh
- Majkl Tolar Martin
|
RU2141952C1 |
N- (PHENYLSULPHONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS |
2017 |
- Wang, Shaomeng
- Chen, Jianyong
|
RU2744358C2 |
TREATING OR PREVENTING PROLIFERATIVE CONDITIONS |
2010 |
- Everett Stiven Albert
- Yulkhak Saradzh
|
RU2705548C2 |